Says care activity increases at twice the rate of 2024. Says “decidedly unsatisfied” with Q1 results. Says Optum Rx off to “strong selling season” in 2025. Comments taken from Q1 earnings conference call.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UNH Earnings: UnitedHealth Stock Crashes on Revised Outlook
- Morgan Stanley expects UnitedHealth shares to fall following guidance cut
- Options Volatility and Implied Earnings Moves Today, April 17, 2025
- UnitedHealth cuts FY25 adjusted EPS view to $26.00-$26.50 from $29.50-$30.00
- UnitedHealth reports Q1 adjusted EPS $7.20, consensus $7.29